title: Leptin upregulates VEGF in breast cancer via canonic and non-canonical signalling pathways and NFkappaB/HIF-1alpha activation.
abstract: High levels of VEGF and leptin are strongly linked to worse prognosis of breast cancer. Leptin signalling upregulates VEGF in human and mouse mammary tumor cells (MT), but the specific molecular mechanisms are largely unknown. Pharmacologic and genetic approaches were used to dissect the mechanism of leptin regulation of VEGF protein and mRNA in MT (4T1, EMT6 and MMT). A series of VEGF-promoter Luc-reporters (full-length and transcription factor-binding deletions) were transfected into MT to analyze leptin regulation of VEGF transcription. Deletion analysis of VEGF promoter and RNA knockdown shows that HIF-1alpha and NFkappaB are essentials for leptin regulation of VEGF. Leptin activation of HIF-1alpha was mainly linked to canonic (MAPK, PI-3K) and non-canonic (PKC, JNK and p38 MAP) signalling pathways. Leptin non-canonic signalling pathways (JNK, p38 MAP and to less extent PKC) were linked to NFkappaB activation. SP1 was involved in leptin regulation of VEGF in 4T1 cells. AP1 was not involved and AP2 repressed leptin-induced increase of VEGF. Overall, these data suggest that leptin signalling regulates VEGF mainly through HIF-1alpha and NFkappaB. These results delineate a comprehensive mechanism for leptin regulation of VEGF in MT. Disruption of leptin signalling could be used as a novel way to treat breast cancer.
authors.affiliation: Department of Microbiology, Biochemistry and Immunology, Morehouse School of Medicine, 720 Westview Drive, Atlanta, GA 30310, USA. rgonzalez@msm.edu
authors.forename: Ruben R
authors.initials: RR
authors.lastname: Gonzalez-Perez
authors.forename: Yanbo
authors.initials: Y
authors.lastname: Xu
authors.forename: Shanchun
authors.initials: S
authors.lastname: Guo
authors.forename: Amber
authors.initials: A
authors.lastname: Watters
authors.forename: Weiqiang
authors.initials: W
authors.lastname: Zhou
authors.forename: Samuel J
authors.initials: SJ
authors.lastname: Leibovich
mesh_terms: D000818:Animals; D045744:Cell Line, Tumor; D016207:Cytokines / Q000378:metabolism; D005260:Female; D015972:Gene Expression Regulation, Neoplastic; D055785:Gene Knockdown Techniques; D051795:Hypoxia-Inducible Factor 1, alpha Subunit / Q000037:antagonists & inhibitors / Q000235:genetics / Q000378:metabolism*; D020738:Leptin / Q000494:pharmacology*; D008325:Mammary Neoplasms, Experimental / Q000235:genetics* / Q000378:metabolism; D051379:Mice; D016328:NF-kappa B / Q000037:antagonists & inhibitors / Q000235:genetics / Q000378:metabolism*; D011401:Promoter Regions, Genetic; D015398:Signal Transduction; D015533:Transcriptional Activation; D015854:Up-Regulation; D042461:Vascular Endothelial Growth Factor A / Q000096:biosynthesis / Q000235:genetics*
chemical_list: D016207:Cytokines; D051795:Hypoxia-Inducible Factor 1, alpha Subunit; D020738:Leptin; D016328:NF-kappa B; D042461:Vascular Endothelial Growth Factor A
references.citation: Cancer Metastasis Rev. 2000;19(1-2):139-45
references.pmid: 11191053
references.citation: Trends Cardiovasc Med. 1998 Aug;8(6):246-50
references.pmid: 14987559
references.citation: Breast Cancer Res. 2009;11(3):R36
references.pmid: 19531256
references.citation: Endocrinology. 2004 Aug;145(8):3850-7
references.pmid: 15142989
references.citation: J Biol Chem. 2008 Oct 17;283(42):28066-73
references.pmid: 18718905
references.citation: Biochem Biophys Res Commun. 2005 Jul 29;333(2):328-35
references.pmid: 15961063
references.citation: Clin Cancer Res. 2004 Jul 1;10(13):4325-31
references.pmid: 15240518
references.citation: J Biol Chem. 1997 Mar 7;272(10):6093-6
references.pmid: 9102398
references.citation: FEBS Lett. 2004 May 7;565(1-3):139-42
references.pmid: 15135067
references.citation: Endocrine. 2001 Oct;16(1):21-8
references.pmid: 11822823
references.citation: J Pathol. 1999 Dec;189(4):514-20
references.pmid: 10629551
references.citation: J Biol Chem. 2004 May 7;279(19):19908-15
references.pmid: 14985328
references.citation: Immunity. 2006 Nov;25(5):701-15
references.pmid: 17098202
references.citation: Cancer Res. 2001 Jul 15;61(14):5407-14
references.pmid: 11454684
references.citation: Biochim Biophys Acta. 2002 Oct 21;1592(2):107-16
references.pmid: 12379472
references.citation: EMBO J. 1997 Feb 17;16(4):750-9
references.pmid: 9049304
references.citation: Growth Factors. 2001;19(1):19-34
references.pmid: 11678207
references.citation: Curr Med Chem. 2005;12(25):2979-94
references.pmid: 16378500
references.citation: Breast Cancer Res Treat. 2006 Jul;98(2):121-32
references.pmid: 16752079
references.citation: Proc Natl Acad Sci U S A. 1998 Jul 7;95(14):7987-92
references.pmid: 9653127
references.citation: Oncogene. 2005 Aug 25;24(36):5552-60
references.pmid: 16007214
references.citation: J Biol Chem. 1996 Feb 16;271(7):3877-83
references.pmid: 8632007
references.citation: Pharmacol Rev. 2007 Jun;59(2):185-205
references.pmid: 17540906
references.citation: J Endocrinol. 2008 Nov;199(2):221-33
references.pmid: 18715880
references.citation: Nature. 2002 Jan 17;415(6869):339-43
references.pmid: 11797013
references.citation: Acta Haematol. 2001;106(4):148-56
references.pmid: 11815711
references.citation: J Cell Physiol. 2001 Sep;188(3):304-12
references.pmid: 11473356
references.citation: Proc Natl Acad Sci U S A. 2000 Sep 26;97(20):10972-7
references.pmid: 10995484
references.citation: Blood. 1999 Sep 1;94(5):1561-7
references.pmid: 10477681
references.citation: Int J Cancer. 2004 Nov 20;112(4):585-95
references.pmid: 15382039
references.citation: J Cell Physiol. 2001 Aug;188(2):223-35
references.pmid: 11424089
references.citation: Cancer Res. 1978 Oct;38(10):3174-81
references.pmid: 210930
references.citation: Mol Biol Cell. 2007 Jan;18(1):14-23
references.pmid: 17065555
references.citation: Biochem J. 2008 Jun 15;412(3):477-84
references.pmid: 18393939
references.citation: Oncogene. 2008 Jan 17;27(4):540-7
references.pmid: 17653093
references.citation: Science. 1998 Sep 11;281(5383):1683-6
references.pmid: 9733517
references.citation: Endocrinology. 2005 Nov;146(11):4917-25
references.pmid: 16123159
references.citation: Cancer Res. 1995 Nov 1;55(21):4844-9
references.pmid: 7585518
references.citation: J Natl Cancer Inst. 2002 Nov 20;94(22):1704-11
references.pmid: 12441326
references.citation: J Biol Chem. 2003 Mar 7;278(10):8190-8
references.pmid: 12509426
references.citation: Cancer Res. 2004 Jan 15;64(2):631-8
references.pmid: 14744778
references.citation: Cancer Res. 1996 May 1;56(9):2013-6
references.pmid: 8616842
references.citation: Front Biosci. 2007 Jan 01;12:2279-90
references.pmid: 17127464
references.citation: J Biol Chem. 2002 Nov 8;277(45):42953-7
references.pmid: 12215445
references.citation: J Cell Physiol. 2003 Jan;194(1):30-44
references.pmid: 12447987
references.citation: Cell Signal. 2002 Aug;14(8):655-63
references.pmid: 12020765
references.citation: Cancer Res. 2001 Sep 15;61(18):6952-7
references.pmid: 11559575
references.citation: Cancer Res. 2002 Sep 1;62(17):4977-84
references.pmid: 12208749
references.citation: Hepatology. 2005 Dec;42(6):1339-48
references.pmid: 16317688
references.citation: Cancer Res. 2008 Dec 1;68(23):9712-22
references.pmid: 19047149
references.citation: Cancer Res. 2000 Jun 1;60(11):2898-905
references.pmid: 10850435
references.citation: Int J Cancer. 2006 Mar 15;118(6):1414-9
references.pmid: 16206269
references.citation: Clin Cancer Res. 2002 Nov;8(11):3487-95
references.pmid: 12429639
references.citation: Nature. 2004 Sep 23;431(7007):461-6
references.pmid: 15329734
references.citation: Nature. 1998 Jul 30;394(6692):485-90
references.pmid: 9697772
references.citation: Int J Cancer. 2008 Dec 15;123(12):2782-90
references.pmid: 18798554
references.citation: J Biol Chem. 1996 Nov 8;271(45):28220-8
references.pmid: 8910439
references.citation: Endocrinology. 2005 Feb;146(2):694-701
references.pmid: 15539553
references.citation: Oncogene. 2004 Feb 5;23(5):1052-63
references.pmid: 14647449
references.citation: J Biol Chem. 2006 Sep 8;281(36):26320-8
references.pmid: 16825198
references.citation: Mol Hum Reprod. 2003 Mar;9(3):151-8
references.pmid: 12606591
references.citation: Exp Biol Med (Maywood). 2003 Jun;228(6):697-705
references.pmid: 12773701